Evommune, Inc.

EVMN · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.9B · 48 employees
16
SEC Filings
$7.21
Close 2026-10-01
48
Employees

Business Summary

Evommune, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates for immune-mediated diseases. Its most advanced product candidates are EVO756 and EVO301. The company is in the research and development stage, has not generated revenues from product sales, and relies on additional financing to fund its operations and advance its pipeline through clinical trials.

Latest Stock Quote

EVMN 2026-10-01 $7.21 O:$8.25 H:$8.3 L:$6.99 Vol:1.5M VWAP:$7.2614
origin leaf: null

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-093932EDGAR111K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001193125-26-337984EDGAR19K words
2025-12-112025-09-300001193125-25-315972EDGAR67K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-010001193125-26-409865EDGAR2K words
2026-09-230001193125-26-399378EDGAR1K words
2026-09-150001193125-26-391390EDGAR4K words
2026-09-090001193125-26-385430EDGAR1K words
2026-08-060001193125-26-337964EDGAR2K words
2026-07-300001193125-26-324972EDGAR1K words
2026-03-050001193125-26-093920EDGAR2K words
2026-02-130001193125-26-049888EDGAR1K words
2026-02-100001193125-26-043771EDGAR2K words
2025-12-110001193125-25-315918EDGAR2K words

16 total filings indexed. 3 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

immune-mediated-diseases biopharmaceuticals

Company Identity

CIK0002044725
TickerEVMN
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.evommune.com
Listed2025-11-06

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 194a4513c520b858d6b08c7a9d9832750b51c1b368b26af4238af3c0d3c8d1e9
parent: 7aa7c3d3eb7519df9cc57710728bac6938cd27db132893ee75b219d99dc818f8
content hash: 1b1471849195751b6a63250a3c55d213c19a665ddcb530af117f97d1e41a621f
signed: 2026-10-13T19:01:15.050Z
sources: 3 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up EVMN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on EVMN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/EVMN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.